Intense pulsed light-based treatment for the improvement of symptoms in glaucoma patients treated with hypotensive eye drops

BACKGROUND: Ocular surface disease in glaucoma patients is a significant ocular co-morbidity that can affect 40% to 59% of these patients worldwide. The current study was aimed at evaluating the potential clinical benefit of an intense pulsed light (IPL)-based treatment in glaucomatous patients with...

Descripción completa

Detalles Bibliográficos
Autores principales: Martinez-de-la-Casa, Jose Maria, Oribio-Quinto, Carlos, Milans-del-Bosch, Almudena, Perez-Garcia, Pilar, Morales-Fernandez, Laura, Garcia-Bella, Javier, Benitez-del-Castillo, Jose Manuel, Garcia-Feijoo, Julian, Piñero, David P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8973810/
https://www.ncbi.nlm.nih.gov/pubmed/35361273
http://dx.doi.org/10.1186/s40662-022-00284-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8973810/
https://www.ncbi.nlm.nih.gov/pubmed/35361273
http://dx.doi.org/10.1186/s40662-022-00284-4

Ejemplares similares